Achievement of RAPID3 and cDAPSA Treatment Targets Is Associated with Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in DMARD-Naive Patients Treated with Apremilast

https://acrabstracts.org/abstract/achievement-of-rapid3-and-cdapsa-treatment-targets-is-associated-with-control-of-articular-and-extra-articular-manifestations-of-active-psoriatic-arthritis-in-dmard-naive-patients-treated-with-apremil/

 

Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)

https://www.eventscribe.com/2020/ACRConvergence/fsPopup.asp?efp=TFNDTVlOVlU4MDYz&PresentationID=787208&rnd=0.4317881&query=apremilast&mode=presinfo

 

For more information, abstracts are available online at https://acrabstracts.org.